Adial Pharmaceuticals, Inc ADIL
$3.67
+1.38%
at last close
Market Cap$10.62 million
P/E Ratio—
Div Yield—
Volume4.5K
52-Week Range
$1.31$10.75
Analyst Ratings
- Consensus
- Buy — 2 Buy · 0 Hold · 0 Sell (2 analysts)
- Avg. Price Target
- $8.50 (+131.6% upside)
Key Stats
- Today's Range
- $3.51 – $3.74
- 50-Day Range
- $3.00 – $7.20
- 52-Week Range
- $1.31 – $10.75
- Volume
- 5K shs
- Average Volume
- 41K shs
- Market Cap
- $10.62 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.00%
- Days to Cover
- 1.00
About Adial Pharmaceuticals, Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
Related Stocks
Compare head-to-head: ADIL vs LLY·ADIL vs JNJ·ADIL vs ABBV·ADIL vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.